The Latest Breaking News from ICU Medical

ICU Medical Inc (NASDAQ:ICUI) reported Q1 sales of $543.1 million vs. Raymond James' estimate of $530 million.  Core ICU beat by $7 million, while newly acquired Smiths Medical missed by $5 million.  With an Outperform rating, the analysts lowered the price target from $265 to $235. Adjusted EPS was $1.82, down from Raymond James' estimate…

Surging chronic diseases worldwide and an aging population should fuel the medical device industry’s growth. Therefore, it could be wise to bet on quality medical device stocks ICU Medical (ICUI) and Natus Medical (NTUS), which are currently trading at discounts to their peers. These stocks are rated Strong Buy in…

ICU Medical (NASDAQ:ICUI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Rising concerns over mounting inflationary pressure and the Fed’s signal that it will raise interest rates several times this year are expected to fuel market turbulence in the near term. So, we think it could be wise to bet on quality growth stocks KBR (KBR), AMN Healthcare (AMN), and ICU…